白云山(00874.HK)：国家药监局批准腹可安片等药品补充申请

Core Viewpoint - Recently, the company announced that its subsidiary, Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd., received the "Drug Supplement Application Approval Notice" from the National Medical Products Administration, enhancing the safety and effectiveness information of several drugs [1] Group 1 - The company obtained approval for the following drugs: Abukuan Tablets, Kunling Pills, Shenxidan, Yiganling Tablets, and Maian Granules [1] - The approval is expected to improve the safety, effectiveness, and rational use of these drugs, thereby enhancing their market competitiveness [1]